Zolpidem and dextromoramide abuse with increased metabolism.
Djezzar
Samira
S
Dugarin
Jean
J
Dally
Sylvain
S
D000328:Adult; D003916:Dextromoramide / Q000009:adverse effects / Q000493:pharmacokinetics*; D004193:Discrimination Learning; D004305:Dose-Response Relationship, Drug; D005059:Euphoria / Q000187:drug effects; D006801:Humans; D006993:Hypnotics and Sedatives / Q000008:administration & dosage / Q000493:pharmacokinetics*; D008297:Male; D008657:Metabolic Clearance Rate; D008691:Methadone / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D009294:Narcotics / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use; D011725:Pyridines / Q000009:adverse effects / Q000493:pharmacokinetics*; D013375:Substance Withdrawal Syndrome / Q000097:blood / Q000523:psychology; D019966:Substance-Related Disorders / Q000097:blood* / Q000523:psychology / Q000534:rehabilitation*; D017211:Treatment Failure; D000077334:Zolpidem
D006993:Hypnotics and Sedatives; D009294:Narcotics; D011725:Pyridines; D000077334:Zolpidem; D003916:Dextromoramide; D008691:Methadone